| Period Ending | 31-Dec-2011 | 31-Dec-2010 | 31-Dec-2009 | 31-Dec-2008 |
|---|
|
Total Revenue
|
233,700,000
|
209,180,000
|
208,808,000
|
235,478,000
| | Cost of Revenue | 115,556,000 | 94,334,000 | 90,819,000 | 100,098,000 | | |
Gross Profit
|
118,144,000
|
114,846,000
|
117,989,000
|
135,380,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 213,179,000 | 188,351,000 | 196,114,000 | 222,904,000 | | | |
Operating Income or Loss
|
20,521,000
|
20,829,000
|
12,694,000
|
12,574,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 20,521,000 | 20,829,000 | 12,694,000 | 12,574,000 |
|
Interest Expense | (7,945,000) | (8,404,000) | (9,425,000) | (16,693,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 1,087,000 | 3,340,000 | 4,496,000 | 867,000 |
|
Minority Interest | (17,843,000) | (5,542,000) | (7,569,000) | (6,800,000) |
|
|
|
Net Income From Continuing Ops | 73,862,000 | 25,580,000 | 21,200,000 | 19,481,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
56,019,000
|
20,038,000
|
13,631,000
|
12,681,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|